NPC 18Alternative Names: NPC-18
Latest Information Update: 25 Aug 2016
At a glance
- Originator Nobelpharma
- Class Fibroblast growth factors; Peptide fragments; Vascular disorder therapies
- Mechanism of Action Angiogenesis inducing agents; Fibroblast growth factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Ear disorders